In vitro gentamicin release from commercially available calcium-phosphate bone substitutes: influence of carrier type on duration of the release profile
2006

Gentamicin Release from Biodegradable Bone Substitutes

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): Stallmann Hein, Faber Chris, Bronckers Antonius LJJ, Nieuw Amerongen Arie V, Wuisman Paul IJM

Primary Institution: VU Medical Center

Hypothesis

The study investigates the in vitro release profile of gentamicin from various biodegradable carrier materials.

Conclusion

The high release achieved shows great promise for clinical application of these biodegradable drug-carriers.

Supporting Evidence

  • All combinations showed initial burst-release of active gentamicin.
  • Two cements had continuous-release for 17 days.
  • The relative release of all cements was higher than previously reported for injectable PMMA-cements.
  • The granules released all gentamicin that had adhered to the surface.

Takeaway

This study looks at how well different materials can release an antibiotic called gentamicin, which helps treat infections in bones.

Methodology

The study compared gentamicin release from six injectable cements and six granule types in a controlled in vitro environment over 21 days.

Limitations

The study's in vitro results may not fully translate to clinical conditions due to differences in physiological parameters.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2474-7-18

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication